Document is current
Any future updates will be listed below
-
Authors
Gao, Fengwei
Xie, Qingyun
Ran, Xiaoyun
Zhao, Xin
Yang, Manyu
Jiang, Kangyi
Mao, Tianyang
Yang, Jiayin
Li, Kun
Wu, Hong
-
Funding
Funding for this research was provided by:
Natural Science Foundation for Young Scientists of Shanxi Province (82173124, 82103533, 81972747, 82203823)
Natural Science Foundation of Sichuan Province (2023NSFSC1877)
Sichuan Province Science and Technology Support Program (2023JDR0077，2022YFQ0077)
- License Information
-
More Information
Article History
Received: 3 July 2024
Accepted: 13 September 2024
First Online: 29 September 2024
Declarations
:
: Drs. Fengwei Gao, Qingyun Xie, Xiaoyun Ran, Xin Zhao, Manyu Yang, Kangyi Jiang, Tianyang Mao, Jiayin Yang, Kun Li, and Hong Wu have no conflicts of interest or financial ties to disclose.
: The study protocol for the use of ICG-HSA complexes and the prospective clinical trial was reviewed and approved by the Clinical Research Ethics Committee of West China Hospital, Sichuan University (approval number: 2023 review (2121)). The study was registered on ClinicalTrials.gov (registration number: NCT06219096). All participants voluntarily agreed to take part in the study and provided written informed consent prior to enrollment. The study was conducted in compliance with the Declaration of Helsinki and all relevant guidelines and regulations for research involving human subjects, human material, or human data. The authors confirm that informed consent was obtained from all study participants.
: The authors confirmed that informed consent was obtained from all subjects.
